- 4-Week # shares sold: 1,333
- 12-Week # shares sold: 2,666
- 24-Week # shares sold: 5,332
Here's what you need to know now for Tuesday, August 29.
The activist fund agreed to delay a director-election proxy fight pending the outcome of the company's strategic review.
Elliott's previous successes in the healthcare space bode well for its chances at athena.
When Paul Singer's activist fund urges 'strategic opportunities' it usually means a sale of the business may not be far off.
The healthcare technology and consulting firm reached a deal with activist investor Paul Singer's fund that ends the threat of a director battle—for now.